Clinical Trial Update: Pyronaridine and Artesunate (3:1) in Children With Acute Uncomplicated Plasmodium Falciparum Malaria [Phase 2]

View source ↗

Summary

Phase 2 trial update on pyronaridine-artesunate (3:1) in children with uncomplicated Plasmodium falciparum malaria; results posted after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Uncomplicated Plasmodium Falciparum Malaria

Drugs mentioned

• Pyronaridine Artesunate (3:1) (pyronaridine artesunate)

Snippet

Sponsor: Medicines for Malaria Venture | Conditions: Uncomplicated Plasmodium Falciparum Malaria | Phase 2 | Status: COMPLETED | Results posted: 2021-11-22